Amwill Healthcare Limited is pleased to announce significant progress in expanding its nationwide presence, underpinned by a strong foothold in Karnataka and encouraging growth across Andhra Pradesh and Telangana.

As part of its strategic growth roadmap, the company has recently extended operations into several high-potential markets including Maharashtra, Tamil Nadu, North East India, Chhattisgarh, and Madhya Pradesh. To support this expansion, Amwill has bolstered its field force with key appointments, including a National Sales Manager, Product Manager, Regional Managers, Area Sales Managers, and Medical Representatives. With the team now fully operational, business activities have successfully commenced across all new territories.

These newly entered markets show strong potential and are expected to contribute significantly to the company’s top-line growth and bottom-line profitability in the coming years. This geographic expansion reflects Amwill’s long-term vision of establishing a robust pan-India presence in the dermatology and cosmeceutical segments.

In addition to territorial growth, Amwill has also strengthened its product portfolio with the launch of UVBREAK Fusion Water Sunscreen—a cutting-edge dermatological innovation. Developed with advanced fusion water technology, the sunscreen offers fast absorption, a non-greasy, non-comedogenic finish, and leaves no white cast, making it ideal for daily use, even on sensitive skin. The product has received positive feedback from both dermatologists and consumers, further reinforcing Amwill’s growing presence in the cosmeceutical space.

Financially, the company remains on a solid foundation. Amwill Healthcare has been completely debt-free since inception and maintains a strong liquidity position with a fund base of over ?50 crore*, held across bank balances, fixed deposits, and debt-oriented mutual fund investments. These funds are being strategically deployed to support ongoing and future expansion plans, ensuring sustained and disciplined growth.

Amwill remains committed to leveraging its financial strength, experienced leadership team, and innovative product portfolio to drive long-term value for shareholders and solidify its position in the Indian healthcare landscape.